Top News Stories
News
Bristol Myers Squibb follows Merck in suing US over Medicare price negotiation program
By Michael PopkeThis is the third lawsuit over the new Medicare program in which Bristol Myers' blood thinner Eliquis is expected to be one of the first 10 drugs subject to price negotiations.









